The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Discrimination Or Discretion? Factors Contributing To Discrimination Of People With Hepatitis C In Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$419,750.00
Summary
Hepatitis C is now the leading communicable disease in Australia and stigma and discrimination have been identified as major barriers to addressing this epidemic. This study builds on our previous work in which we have found evidence of discrimination against people with hepatitis C in health care settings. Discrimination, inappropriate and unfair treatment against people with hepatitis C, in health care settings is a major barrier to care, treatment and support. A key strategy for developing ef ....Hepatitis C is now the leading communicable disease in Australia and stigma and discrimination have been identified as major barriers to addressing this epidemic. This study builds on our previous work in which we have found evidence of discrimination against people with hepatitis C in health care settings. Discrimination, inappropriate and unfair treatment against people with hepatitis C, in health care settings is a major barrier to care, treatment and support. A key strategy for developing effective strategies to reduce both perceived and real discrimination of people with hepatitis C in health care settings is to gain a better understanding of the range of issues experienced by the health care providers themselves and factors in the broader health service context that impact on optimal care. The aim of this study is to identify these factors and the findings will influence policy and practice with the ultimate goal of removing barriers to equitable and appropriate health care for people with hepatitis C. The study will focus on both people (health care providers)- the knowledge, attitudes and practices among health care professionals in relation to infection control practices, hepatitis C and injecting drug use; and contexts (health care settings)- factors in the health care settings that contribute to discriminatory, inappropriate or unfair treatment of people with hepatitis C. The study will focus specifically on health care settings of general practice, dentistry, nursing and pharmacists. The outcomes will be used to develop practical and effective strategies for both improving health care for HCV positive individuals and improving the working relationships and environments for these health professionals working with this client population.Read moreRead less
I am infectious disease physician undertaking research on natural history and therapeutic strategies in viral hepatitis, including acute hepatitis C, chronic hepatitis C and chronic hepatitis B. The hepatitis C therapeutic research has a particular focus
Screening For Chlamydia Trachomatis With Routine Pap Smears In General Practice: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$350,500.00
Summary
Genital chlamydia infection is the most commonly reported infectious disease in Australia. Notifications have increased three fold since 1995; five-fold in the ACT and surveillance data underestimate the true incidence of the disease in the community. Chlamydia is associated with immediate morbidity in men and women including urethritis, epididymo-orchitis, cervicitis, and pelvic pain and long-term complications including pelvic inflammatory disease, ectopic pregnancy and tubal factor infertilit ....Genital chlamydia infection is the most commonly reported infectious disease in Australia. Notifications have increased three fold since 1995; five-fold in the ACT and surveillance data underestimate the true incidence of the disease in the community. Chlamydia is associated with immediate morbidity in men and women including urethritis, epididymo-orchitis, cervicitis, and pelvic pain and long-term complications including pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility. The economic costs of Chlamydial infection in Australia have been estimated to be as high as $160 million each year. In the ACT 73.8% of chlamydial infections occur in the 20-40 year old group. Between 60 and 70% of women in this age range participate in Pap screening every two years. While targeted screening for Chlamydia in women is effective in the US, there are few studies that investigate its value in an Australian setting. In this randomised controlled clinical trial we aim to test the novel hypothesis that the routine offer of chlamydia testing to women between 20 and 40 years who undergo Pap screening significantly increases the detection of Chlamydia in that population. This is the first randomised-controlled trial of its type and is an extension of a current non-randomised pilot study of linked Chlamydia-Pap screening in the primary care setting. The aim is to determine if the program can be incorporated more widely in the ACT. The study will: Measure the impact of linked chlamydia-Pap screening on chlamydia screening participation rates More accurately determine the epidemiology of genital chlamydial infection in this age group and social setting; Undertake an economic evaluation of this approach; Determine if promoting the Pap smear as an opportunity for chlamydial screening increases the uptake of Pap screening in younger women Aid in the development of a National Chlamydia Screening strategyRead moreRead less
Eliminating Hepatitis C Transmission By Enhancing Hepatitis C Care And Treatment In Primary Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$1,221,831.00
Summary
In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.
Understanding The Impact Of Harm Reduction Program Coverage On The Incidence Of Blood Borne Viruses And Related Risk Behaviours
Funder
National Health and Medical Research Council
Funding Amount
$86,073.00
Summary
The provision of clean injecting equipment to people who inject drugs (PWID) is a crucial harm reduction intervention that has helped reduce the spread of blood borne viruses. The level to which PWID needs are adequately met is known as “coverage”, and it is the aim of this study to examine how variations in coverage impacts on PWID risk behaviours and health outcomes over time. This project will make important contributions to the evidence base for harm reduction and future implementation.
Life Threatening Cancer Across The Lifespan: Examining The Relevance Of Music To Patients And Their Companions
Funder
National Health and Medical Research Council
Funding Amount
$137,000.00
Summary
Although music is widely used, scant discussion about its therapeutic merit exists when compared to the spoken word. Throughout the Ages, ritualized music promoted health and loss adjustment, however, music is not pivotal in modern medicine. The research will examine people’s intuitive music usage when experiencing life threatening cancer and the relationship between music therapy participation and one’s later music experience. Findings will inform specific recommendations for music therapists a ....Although music is widely used, scant discussion about its therapeutic merit exists when compared to the spoken word. Throughout the Ages, ritualized music promoted health and loss adjustment, however, music is not pivotal in modern medicine. The research will examine people’s intuitive music usage when experiencing life threatening cancer and the relationship between music therapy participation and one’s later music experience. Findings will inform specific recommendations for music therapists and generic guidelines to extend music’s therapeutic effect in palliative care.Read moreRead less
Epidemiology, Natural History And Treatment Of Hepatitis C Virus Infection In Injecting Drug Users
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
In Australia, the majority of hepatitis C is acquired by injecting drug users (IDUs). Given the asymptomatic nature of infection and difficulties in identifying and following those at risk of acquiring infection, our knowledge of hepatitis C has been hampered. The overall goal of this proposed research is to assess markers to better diagnose and predict clearance of hepatitis C, assess hepatitis C transmission and assess health services to enhance HCV assessment and treatment among IDUs.
Models Of Care For Hepatitis C In The Era Of Directly Acting Antivirals
Funder
National Health and Medical Research Council
Funding Amount
$124,608.00
Summary
This project aims to evaluate how service delivery can enhance the impact of directly acting antivirals (DAA) on hepatitis C treatment uptake in three parts: i) To assess the impact of ten integrated hepatology nurses on treatment uptake in Victoria ii) To assess the feasibility of patient driven contact tracing to treat hepatitis C with DAA in a study of people who inject drugs iii) To assess the impact of offering DAA therapy in primary health care compared with a hospital.